Cary Street Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Cary Street Partners's AMGN Position: Q2 2026 in Review
Cary Street Partners increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $156K and bringing the position to 17,422 shares worth $6.31M. The position accounts for 0.14% of the portfolio, ranked #163.
Cary Street Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cary Street Partners held 17,422 shares of Amgen worth $6.31M as of Q2 2026.
- Cary Street Partners bought 455 Amgen shares in Q2 2026, an estimated $156K.
- Amgen made up 0.14% of Cary Street Partners's portfolio in Q2 2026, its #163 holding.
- Cary Street Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.